Ultrastructural observation of filtration membrane in cell‐free and concentrated ascites reinfusion therapy for malignant ascites

Abstract

Introduction: Cell-free and concentrated ascites reinfusion therapy (CART) is used for the treatment of diuretic-resistant ascites. An increase in circuit pressure and clogging of the filtration membrane often occur in CART for malignant ascites. Methods: To clarify the precise mechanism of filter clogging, we performed an ultrastructural observation study of the filtration membrane after the filtration of malignant ascites. Results:The deposition on the filtration membrane was composed of blood cells, fibrin, or both. Cellular deposition was associated with a greater number of blood cells in the original ascites fluid. In contrast, fibrin deposition was associated with higher levels of interleukin-6, α1-antitrypsin, haptoglobin, and fibrinogen/fibrin degradation products. Conclusion:Our results suggest that the specific pathophysiologies of malignancy (such as inflammation or coagulation/fibrinolysis) and characteristics of malignant ascites (highly concentrated and cell-rich) are associated with clogging of the filtration membrane during CART.

Novel and highly reliable leak check tests for drop‐ and external pressure‐type cell‐free and concentrated ascites reinfusion therapy

“…In addition to these useful proteins, ascites may contain harmful substances, such as bacteria, endotoxins, and various cells, including malignant cells, white blood cells, and red blood cells. These substances may cause various adverse events if they enter the patient's circulatory system [3][4][5][6][7][8]. Therefore, it is necessary to remove these harmful substances from the collected ascites.…”